Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Fukang Pharmaceutical is a prominent Chinese pharmaceutical enterprise primarily focused on the production of vitamins and active pharmaceutical ingredients (APIs). Established in 1993 and headquartered in Lanxi, Zhejiang, the company has become one of the world's largest manufacturers of Vitamin B1 (Thiamine), supplying a significant portion of the global market. Their operations include large-scale chemical synthesis and manufacturing facilities that adhere to international quality standards such as GMP, CEP, and FDA requirements. Beyond vitamins, the company produces various pharmaceutical intermediates and finished dosage forms for global distribution. Zhejiang Fukang is recognized for its high-volume production capabilities and its role as a key supplier to the global food, feed, and pharmaceutical industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Fukang Pharmaceutical.